-
EP2027085
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2027085
| EP2027085 - PROSTAGLANDIN EP4 AGONISTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 05.02.2016 Database last updated on 28.03.2026 | Most recent event Tooltip | 05.02.2016 | Application deemed to be withdrawn | published on 09.03.2016 [2016/10] | Applicant(s) | For all designated states ALLERGAN, INC. 2525 Dupont Drive Irvine, CA 92612 / US | [N/P] |
| Former [2009/09] | For all designated states ALLERGAN, INC. 2525 Dupont Drive Irvine CA 92612 / US | ||
| Former [2008/36] | For all designated states Allergan Inc. 2525 Dupont Drive Irvine, CA 92612 / US | Inventor(s) | 01 /
IM, Wha, Bin 70 Palatine, Apt. 305 Irvine, CA 92612 / US | 02 /
BURK, Robert, M. 1337 Cerritos Drive Laguna Beach, CA 92651 / US | 03 /
HOLOBOSKI, Mark 29342 Bobolink Drive Laguna Niguel, CA 92677 / US | [2009/09] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastrasse 30 81925 München / DE | [N/P] |
| Former [2009/09] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE | Application number, filing date | 07758870.5 | 20.03.2007 | [2009/09] | WO2007US64360 | Priority number, date | US20060744234P | 04.04.2006 Original published format: US 744234 P | [2009/09] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2007115001 | Date: | 11.10.2007 | Language: | EN | [2007/41] | Type: | A1 Application with search report | No.: | EP2027085 | Date: | 25.02.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.10.2007 takes the place of the publication of the European patent application. | [2009/09] | Search report(s) | International search report - published on: | EP | 11.10.2007 | Classification | IPC: | C07C405/00, A61K31/5575, A61P1/04 | [2009/09] | CPC: |
A61K31/5575 (EP,KR,US);
C07C405/00 (EP,KR,US);
C07D333/56 (EP,US);
A61P1/04 (EP);
A61P43/00 (EP);
C07D211/74 (EP,US);
C07D211/76 (EP,US);
C07D333/62 (EP,US);
C07D333/68 (EP,US);
C07D409/06 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/09] | Title | German: | PROSTAGLANDIN-EP4-AGONISTEN | [2009/09] | English: | PROSTAGLANDIN EP4 AGONISTS | [2009/09] | French: | AGONISTES DE LA PROSTAGLANDINE EP4 | [2009/09] | Entry into regional phase | 22.10.2008 | National basic fee paid | 22.10.2008 | Designation fee(s) paid | 22.10.2008 | Examination fee paid | Examination procedure | 22.10.2008 | Examination requested [2009/09] | 16.04.2009 | Despatch of a communication from the examining division (Time limit: M06) | 26.10.2009 | Reply to a communication from the examining division | 03.12.2010 | Despatch of a communication from the examining division (Time limit: M06) | 27.05.2011 | Reply to a communication from the examining division | 16.05.2012 | Despatch of a communication from the examining division (Time limit: M04) | 17.09.2012 | Reply to a communication from the examining division | 12.08.2013 | Despatch of a communication from the examining division (Time limit: M06) | 12.02.2014 | Reply to a communication from the examining division | 01.10.2015 | Application deemed to be withdrawn, date of legal effect [2016/10] | 26.10.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2016/10] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 16.04.2009 | Fees paid | Renewal fee | 26.03.2009 | Renewal fee patent year 03 | 25.03.2010 | Renewal fee patent year 04 | 29.03.2011 | Renewal fee patent year 05 | 26.03.2012 | Renewal fee patent year 06 | 27.03.2013 | Renewal fee patent year 07 | 27.03.2014 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 31.03.2015 | 09 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | Examination | US2006035963 | WO2004063158 | EP1481976 | CHOURASIA M K: "PHARMACEUTICAL APPROACHES TO COLON TARGETED DRUG DELIVERY SYSTEMS", JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, CANADIAN SOCIETY FOR PHARMACEUTICAL SCIENCES, EDMONTON, CA, vol. 6, no. 1, 1 January 2003 (2003-01-01), pages 33 - 66, XP008078133, ISSN: 1482-1826 | WIPF P ET AL: "SYNTHESIS OF CHEMOREVERSIBLE PRODRUGS OF ARA-C WITH VARIABLE TIME-RELEASE PROFILES, BIOLOGICAL EVALUATION OF THEIR APOPTOTIC ACTIVITY", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 4, no. 10, 1 January 1996 (1996-01-01), pages 1585 - 1596, XP009066434, ISSN: 0968-0896, DOI: 10.1016/0968-0896(96)00153-8 DOI: http://dx.doi.org/10.1016/0968-0896(96)00153-8 | "Prostaglandin tyrosine alkyl ester amides - prepd by reacting prostaglandin and tyrosine esters in presence of dicyclohexylcarbodiimide", DERWENT, XP002370551 | ANDERSON B D ET AL: "PROSTAGLANDIN PRODRUGS. VI: STRUCTURE-THERMODYNAMIC ACTIVITY AND STRUCTURE-AQUEOUS SOLUBILITY RELATIONSHIPS", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, US, vol. 69, no. 4, 1 April 1980 (1980-04-01), pages 424 - 430, XP008060923, ISSN: 0022-3549, DOI: 10.1002/JPS.2600690417 DOI: http://dx.doi.org/10.1002/jps.2600690417 | SPRINGER C J ET AL: "Gene-directed enzyme prodrug therapy", 1 January 2002, ANTICANCER DRUG DEVELOPMENT, SAN DIEGO : ACADEMIC PRESS, PAGE(S) 137 - 155, ISBN: 0-12-072651-3, XP009159194 | MARUYAMA T ET AL: "DESIGN AND SYNTHESIS OF A SELECTIVE EP4-RECEPTOR AGONIST. PART 4: PRACTICAL SYNTHESIS AND BIOLOGICAL EVALUTION OF A NOVEL HIGHLY SELECTIVE EP4-RECEPTOR AGONIST", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 10, 1 January 2002 (2002-01-01), pages 2103 - 2110, XP001222023, ISSN: 0968-0896, DOI: 10.1016/S0968-0896(02)00085-8 DOI: http://dx.doi.org/10.1016/S0968-0896(02)00085-8 | KAJINO H ET AL: "An EP4 receptor agonist prevents indomethacin-induced closure of rat ductus arteriosus in vivo", PEDIATRIC RESEARCH, NATURE PUBLISHING GROUP, US, vol. 56, no. 4, 3 August 2004 (2004-08-03), pages 586 - 590, XP002370490, ISSN: 0031-3998, DOI: 10.1203/01.PDR.0000139409.25014.35 DOI: http://dx.doi.org/10.1203/01.PDR.0000139409.25014.35 |